Search results
Gateway - Quartz
Quartz· 1 day agoJPMorgan Chase’s asset management division just finished raising a $500 million biotech fund, and its managers are looking at weight loss drug investments. Johnson & Johnson ...
Amazon Pharmacy expands to Medicare enrollees
The Hill via Yahoo News· 2 days agoAmazon Pharmacy will expand its subscription service to enrollees of Medicare insurance plans, the company announced Tuesday. The expansion will be...
Niemann-Pick disease type C: Rare disease patients awaiting disease-modifying drugs
Pharmaceutical Technology via Yahoo Finance· 3 days agoIn the US, miglustat is not approved for NPC, and it is used off...the only therapeutic option for...
Drugmaker Apotex accuses Amarin of Vascepa monopoly in US lawsuit
Reuters· 3 days agoDrugmaker Apotex has sued its rival Amarin in federal court in New Jersey, accusing it of thwarting...
Is the Inflation Reduction Act failing Oklahoma’s senior citizens? | Opinion
The Oklahoman via Yahoo News· 22 hours agoSeniors struggling with illness are also looking for new drugs to prolong and improve their lives....
Drug shortages keep on growing. Older, injectable medicines are among the most vulnerable
Associated Press· 3 days agoErin Fox has tracked drug shortages for more than 20 years, and she sees no easy solutions for what...
Teva Engages In Settlement Talks Over Medicare Kickback Allegations - Teva Pharmaceutical Indus...
Benzinga· 2 days agoCiting a filing, Reuters noted the company is requesting the Boston-based 1st U.S. Circuit Court of Appeals to delay its upcoming appeal hearing. Also Read: Generics ...
Gateway - Quartz
Quartz· 1 day ago“Lilly’s got a lead,” Ricks told the Wall Street Journal in an interview, “and we plan to exploit that lead.” Tirzepatide is a GLP-1 medication, the same class as ...
Doctors Test the Limits of What Obesity Drugs Can Fix
New York Times· 2 days ago“Obesity first” doctors say they start with one pill, to treat obesity, and often find other chronic...
3 Top Stocks I'd Buy Today and Hold Forever Without Any Hesitation
The Motley Fool via AOL· 2 days agoRather than allow its market share to be eaten by generic medicines, the company is constantly...
